Dean Y. Li

Insider Reports History

Entity
Individual
Location
2000 Galloping Hill Road, Kenilworth, NJ
Signature
/s/ Kyle Nelson, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dean Y. Li:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RECURSION PHARMACEUTICALS, INC. Director Class A Common Stock 1.42M $8.59M $6.04 Apr 1, 2025 By Dean Li and Ruth Li Revocable Trust
Merck & Co., Inc. Executive VP & President, MRL Common Stock 79.6K $7.8M $97.94 Jan 27, 2025 Direct
RECURSION PHARMACEUTICALS, INC. Director Class A Common Stock 1.27M $7.67M $6.04 Apr 1, 2025 By Dean Y. Li GRAT
RECURSION PHARMACEUTICALS, INC. Director Class A Common Stock 421K $2.54M $6.04 Apr 1, 2025 By Dean Y. Li 2021 Family Trust
RECURSION PHARMACEUTICALS, INC. Director Class A Common Stock 79.6K $481K $6.04 Apr 1, 2025 Direct
Merck & Co., Inc. Executive VP & President, MRL Stock Option (Right to Buy) 65.6K Apr 30, 2024 Direct
RECURSION PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 26.2K Jun 3, 2024 Direct

Insider Reports Filed by Dean Y. Li

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RXRX RECURSION PHARMACEUTICALS, INC. Apr 1, 2025 1 $0 4 Apr 3, 2025 Director
MRK Merck & Co., Inc. Jan 27, 2025 1 $3.19M 4 Jan 29, 2025 Executive VP & President, MRL
RXRX RECURSION PHARMACEUTICALS, INC. Jan 2, 2025 1 $0 4 Jan 6, 2025 Director
RXRX RECURSION PHARMACEUTICALS, INC. Oct 1, 2024 1 $0 4 Oct 4, 2024 Director
RXRX RECURSION PHARMACEUTICALS, INC. Jul 1, 2024 1 $0 4 Jul 3, 2024 Director
RXRX RECURSION PHARMACEUTICALS, INC. Jun 3, 2024 2 $0 4 Jun 5, 2024 Director
MRK Merck & Co., Inc. Apr 30, 2024 1 $0 4 May 2, 2024 Executive VP & President, MRL
RXRX RECURSION PHARMACEUTICALS, INC. Apr 1, 2024 1 $0 4 Apr 3, 2024 Director
MRK Merck & Co., Inc. Feb 9, 2024 3 -$933K 4 Feb 12, 2024 Executive VP & President, MRL
MRK Merck & Co., Inc. Jan 22, 2024 1 $3.08M 4 Jan 24, 2024 Executive VP & President, MRL
RXRX RECURSION PHARMACEUTICALS, INC. Jan 9, 2024 2 -$396K 4 Jan 11, 2024 Director
RXRX RECURSION PHARMACEUTICALS, INC. Jan 2, 2024 1 $0 4 Jan 4, 2024 Director
RXRX RECURSION PHARMACEUTICALS, INC. Jul 3, 2023 1 $0 4 Jul 6, 2023 Director
RXRX RECURSION PHARMACEUTICALS, INC. Jun 16, 2023 2 $0 4 Jun 21, 2023 Director
MRK Merck & Co., Inc. May 2, 2023 1 $0 4 May 4, 2023 Executive VP & President, MRL
MRK Merck & Co., Inc. May 1, 2023 3 $62.1K 4 May 3, 2023 Executive VP & President, MRL
RXRX RECURSION PHARMACEUTICALS, INC. Apr 21, 2023 2 $0 4 Oct 4, 2023 Director
RXRX RECURSION PHARMACEUTICALS, INC. Apr 3, 2023 1 $0 4 Apr 5, 2023 Director
MRK Merck & Co., Inc. Jan 23, 2023 1 $360K 4 Jan 25, 2023 Executive VP & President, MRL
RXRX RECURSION PHARMACEUTICALS, INC. Jan 3, 2023 1 $0 4 Jan 5, 2023 Director
RXRX RECURSION PHARMACEUTICALS, INC. Oct 3, 2022 1 $0 4 Oct 5, 2022 Director
RXRX RECURSION PHARMACEUTICALS, INC. Jul 1, 2022 1 $0 4 Jul 6, 2022 Director
RXRX RECURSION PHARMACEUTICALS, INC. Jun 14, 2022 2 $0 4 Jun 16, 2022 Director
MRK Merck & Co., Inc. May 3, 2022 1 $0 4 May 5, 2022 Executive VP & President, MRL
MRK Merck & Co., Inc. May 3, 2022 3 $34.4K 4 May 4, 2022 Executive VP & President, MRL
MRK Merck & Co., Inc. May 1, 2022 3 $47.7K 4 May 3, 2022 Executive VP & President, MRL
RXRX RECURSION PHARMACEUTICALS, INC. Apr 1, 2022 1 $0 4 Apr 5, 2022 Director
MRK Merck & Co., Inc. Feb 24, 2022 1 $222K 4 Feb 28, 2022 Executive VP & President, MRL
RXRX RECURSION PHARMACEUTICALS, INC. Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
RXRX RECURSION PHARMACEUTICALS, INC. Dec 7, 2021 2 -$326K 4 Dec 9, 2021 Director
RXRX RECURSION PHARMACEUTICALS, INC. Nov 17, 2021 2 -$385K 4/A Dec 9, 2021 Director
RXRX RECURSION PHARMACEUTICALS, INC. Oct 1, 2021 1 $0 4 Oct 5, 2021 Director
RXRX RECURSION PHARMACEUTICALS, INC. Jul 1, 2021 1 $0 4 Jul 6, 2021 Director